应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
APG APi Group Corp
盘前交易 12-23 05:13:10 EST
36.92
+0.32
+0.87%
最高
37.73
最低
36.10
成交量
189.92万
今开
36.10
昨收
36.60
日振幅
4.45%
总市值
101.45亿
流通市值
79.70亿
总股本
2.75亿
成交额
7,065万
换手率
0.88%
流通股本
2.16亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
澳门回归25周年|澳门金融业的跨越式发展
媒体滚动 · 12-20
澳门回归25周年|澳门金融业的跨越式发展
港股异动 | 亚盛医药-B(06855)午后涨超7% 耐立克和APG-2575展现突出疗效 机构看好公司未来营收高增
智通财经 · 12-19
港股异动 | 亚盛医药-B(06855)午后涨超7% 耐立克和APG-2575展现突出疗效 机构看好公司未来营收高增
Api Group Corporation盘中异动 大幅拉升5.14%
市场透视 · 12-05
Api Group Corporation盘中异动 大幅拉升5.14%
BUZZ--美国股票走势-CC 控股公司、世邦魏理仕、莱克西康制药公司
Reuters · 11-23
BUZZ--美国股票走势-CC 控股公司、世邦魏理仕、莱克西康制药公司
BUZZ-亚太集团首席财务官离职;股价下跌
Reuters · 11-22
BUZZ-亚太集团首席财务官离职;股价下跌
半年股价实现2倍增幅,亚盛医药-B(06855)APG-2575商业化在即估值新增量可期
智通财经 · 11-18
半年股价实现2倍增幅,亚盛医药-B(06855)APG-2575商业化在即估值新增量可期
亚盛医药-B(06855):APG-2575新药上市申请获中国国家药品监督管理局药品审评中心受理,并被推荐纳入优先审评
智通财经 · 11-17
亚盛医药-B(06855):APG-2575新药上市申请获中国国家药品监督管理局药品审评中心受理,并被推荐纳入优先审评
Api Group Corporation2024财年第三财季实现净利润69.00百万美元,同比增加27.78%
市场透视 · 11-10
Api Group Corporation2024财年第三财季实现净利润69.00百万美元,同比增加27.78%
Api Group Corporation盘中异动 急速拉升5.01%报36.87美元
市场透视 · 11-07
Api Group Corporation盘中异动 急速拉升5.01%报36.87美元
【2024 ASH】 亚盛医药Bcl-2抑制剂APG-2575三项临床研究入选,含1项口头报告!
美通社 · 11-06
【2024 ASH】 亚盛医药Bcl-2抑制剂APG-2575三项临床研究入选,含1项口头报告!
亚盛医药-B(06855):耐立克®、lisaftoclax、APG-5918及APG-2449的多项临床进展将在2024年美国血液学会年会(ASH)展示,其中两项获口头报告
智通财经 · 11-06
亚盛医药-B(06855):耐立克®、lisaftoclax、APG-5918及APG-2449的多项临床进展将在2024年美国血液学会年会(ASH)展示,其中两项获口头报告
港股异动 | 亚盛医药-B(06855)再涨超4% APG-2449获批开展III期临床研究 赴美上市有望开启新阶段
智通财经网 · 10-17
港股异动 | 亚盛医药-B(06855)再涨超4% APG-2449获批开展III期临床研究 赴美上市有望开启新阶段
港股异动 | 亚盛医药-B(06855)现涨近9% APG-2449获准开展治疗非小细胞肺癌III期临床研究
智通财经 · 10-16
港股异动 | 亚盛医药-B(06855)现涨近9% APG-2449获准开展治疗非小细胞肺癌III期临床研究
港股异动 | 亚盛医药-B(06855)涨超4% APG-2449获CDE许可开展治疗非小细胞肺癌的注册III期临床研究
智通财经 · 10-08
港股异动 | 亚盛医药-B(06855)涨超4% APG-2449获CDE许可开展治疗非小细胞肺癌的注册III期临床研究
亚盛医药-B(06855):APG-2449获CDE许可开展治疗非小细胞肺癌的注册III期临床研究
智通财经 · 10-08
亚盛医药-B(06855):APG-2449获CDE许可开展治疗非小细胞肺癌的注册III期临床研究
Crypto反洗钱:国际监管和愈发严格的信息披露义务
TaxDAO · 10-02
Crypto反洗钱:国际监管和愈发严格的信息披露义务
【金融行动特别工作组(FATF)敦促印度加强虚拟资产监管】金色财经报道,金融行动特别工作组(FATF)周四宣布,在与亚太反洗钱组织(APG)和欧亚集团(EAG)进行联合评估后,印度已“在技术上高度遵守了 FATF 建议,并已采取重大措施实施打击非法融资”。
金色财经 · 09-21
【金融行动特别工作组(FATF)敦促印度加强虚拟资产监管】金色财经报道,金融行动特别工作组(FATF)周四宣布,在与亚太反洗钱组织(APG)和欧亚集团(EAG)进行联合评估后,印度已“在技术上高度遵守了 FATF 建议,并已采取重大措施实施打击非法融资”。
亚太股份注资2.5万欧元在德国设立全资子公司APG GmbH
财中社 · 09-20
亚太股份注资2.5万欧元在德国设立全资子公司APG GmbH
Api Group Corporation2024财年第二财季实现净利润69.00百万美元,同比增加43.75%
自选股智能写手 · 08-11
Api Group Corporation2024财年第二财季实现净利润69.00百万美元,同比增加43.75%
巴克莱:维持APi Gr(APG.US)评级,由增持调整至增持评级, 目标价由44.00美元调整至43.00美元。
智通财经 · 08-06
巴克莱:维持APi Gr(APG.US)评级,由增持调整至增持评级, 目标价由44.00美元调整至43.00美元。
加载更多
公司概况
公司名称:
APi Group Corp
所属市场:
NYSE
上市日期:
--
主营业务:
APi Group Corporation是特拉华州的一家公司。该公司是一家全球性的、市场领先的商业服务提供商,在全球500多个地点提供安全和专业服务。该公司向各行各业的长期客户提供法定授权服务和其他合同服务。该公司拥有一种成功的领导文化,这种文化是由向客户提供创新解决方案的创业型商业领袖推动的。
发行价格:
--
{"stockData":{"symbol":"APG","market":"US","secType":"STK","nameCN":"APi Group Corp","latestPrice":36.92,"timestamp":1734728399258,"preClose":36.6,"halted":0,"volume":1899216,"delay":0,"floatShares":215866537,"shares":274775770,"eps":-1.711013,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.32,"latestTime":"12-23 05:13:10 EST","open":36.1,"high":37.73,"low":36.1,"amount":70653655.53576,"amplitude":0.044536,"askPrice":42.11,"askSize":100,"bidPrice":36.94,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-1.711013,"exchange":"NYSE","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"adjPreClose":36.94,"postHourTrading":{"tag":"盘后","latestPrice":36.94,"preClose":36.94,"latestTime":"18:48 EST","volume":387526,"amount":14314563.319,"timestamp":1734738535466},"volumeRatio":1.1030823122319113,"impliedVol":0.2104,"impliedVolPercentile":0.316},"requestUrl":"/m/hq/s/APG","defaultTab":"news","newsList":[{"id":"2492468483","title":"澳门回归25周年|澳门金融业的跨越式发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2492468483","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492468483?lang=zh_cn&edition=full","pubTime":"2024-12-20 12:21","pubTimestamp":1734668460,"startTime":"0","endTime":"0","summary":"澳门银行业的资产规模由此得以迅速扩张,公司金融、个人金融和金融市场业务全面发展。澳门金融业依法合规经营获国际认可回归以来,澳门金融业持续、稳健增长,发展质量及监管水平得到国际组织的广泛认可。澳门金融业积极融入国家发展大局澳门回归后,澳门金融业既是在国家政策红利下实现跨越式发展的“受益者”,更是为澳门融入国家战略大局作出独特贡献的“建设者”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/bank/yhpl/2024-12-20/doc-ineaarnx6029680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2125909759.SGD","LU1923622291.USD","APG","BK4129","LU2125909916.SGD"],"gpt_icon":0},{"id":"2492115400","title":"港股异动 | 亚盛医药-B(06855)午后涨超7% 耐立克和APG-2575展现突出疗效 机构看好公司未来营收高增","url":"https://stock-news.laohu8.com/highlight/detail?id=2492115400","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492115400?lang=zh_cn&edition=full","pubTime":"2024-12-19 13:39","pubTimestamp":1734586744,"startTime":"0","endTime":"0","summary":"消息面上,亚盛医药的耐立克与APG-2575 均在ASH大会上展现多项临床数据。同时,APG-2575在MM和MDS中均展现良好的初步疗效数据。展望未来,全球上市加速,核心产品有望于2026-2027年进入美国市场,预计在2024年APG-2575将递交NDA申请,并于2025年在中国获批上市,同时耐立克医保覆盖范围将进一步增加。此外,耐立克预计在2026年完成POLARIS-2临床试验并在美国提交NDA 申请,最快可于同年在美国上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226930.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","APG","159938","06855"],"gpt_icon":0},{"id":"2489457444","title":"Api Group Corporation盘中异动 大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489457444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489457444?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:33","pubTimestamp":1733409183,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时33分,Api Group Corporation股票出现异动,股价快速上涨5.14%。Api Group Corporation股票所在的建筑工程行业中,整体跌幅为0.16%。其相关个股中,Api Group Corporation、花岗岩建筑、Orion Group Holdings, Inc.涨幅较大,钧御工程、Founder Group Limited、Skk Holdings Limited较为活跃,换手率分别为1.66%、0.87%、0.62%,振幅较大的相关个股有Ming Shing Group Holdings Limited、Reitar Logtech Holdings Limited、Founder Group Limited,振幅分别为13.89%、8.18%、6.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522330398e59e00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522330398e59e00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2125909916.SGD","BK4129","LU2125909759.SGD","APG","LU1923622291.USD"],"gpt_icon":0},{"id":"2485929061","title":"BUZZ--美国股票走势-CC 控股公司、世邦魏理仕、莱克西康制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2485929061","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485929061?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:48","pubTimestamp":1732301316,"startTime":"0","endTime":"0","summary":"** Arm Holdings PLC : BUZZ - 富国银行将其评级定为 \"增持\"。** Copart Inc : BUZZ - 因飓风过后的销售而实现季度营收增长。** Tapestry Inc : BUZZ - 在 20 亿美元的加速股票回购计划后涨至逾十年新高 ** Eyenovia Inc : BUZZ - 因采取更多削减成本行动和推迟债务偿还而上涨 ** Reddit Inc : BUZZ - 在腾讯披露股票销售后从创纪录水平回落。** Viking Therapeutics Inc : BUZZ--上涨;B.Riley给予 \"买入 \"评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSQ","QLD","QID","TPR","HALO","INTU","VTRS","CYH","SLG","NTAP","WAY","THC","HON","BKE","CPRT","NEM",".IXIC",".SPX","VKTX","DOG","WTW","LIPO","FFWM","CBG","CTXR","ROST","EYEN","RUN","AMIX","LXRX","JTAI","AXP","HCA",".DJI","DJX","APG","EOG","FLEX","CC","CBRE"],"gpt_icon":1},{"id":"2485267072","title":"BUZZ-亚太集团首席财务官离职;股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2485267072","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485267072?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:43","pubTimestamp":1732290239,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 11月22日 - ** APi 集团公司 股价下跌 0.9% 至 36.68 美元** 这家消防和生命安全服务提供商的 首席财务官凯文-克鲁姆(Kevin Krumm)将于2024年12月13日卸任。** 在克鲁姆离职后,APi 国际公司现任转型首席财务官 David Jackola 将担任 临时首席财务官。** 克鲁姆将加入 Flex Ltd ,担任首席财务官,2025 年 1 月 6 日生效** APG 重申了其 2024 年净营收和调整后 EBITDA 指导目标** APG 股价今年累计上涨约 7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125909916.SGD","LU1923622291.USD","LU2125909759.SGD","BK4129","APG"],"gpt_icon":0},{"id":"2484699465","title":"半年股价实现2倍增幅,亚盛医药-B(06855)APG-2575商业化在即估值新增量可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2484699465","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484699465?lang=zh_cn&edition=full","pubTime":"2024-11-18 12:24","pubTimestamp":1731903847,"startTime":"0","endTime":"0","summary":"回顾APG-2575的研发路程,自2018年以来,亚盛医药始终在APG-2575的研发和商业化进程上稳步推进,并不断取得重要阶段性成果。而此次APG-2575在国内NDA获受理并被推荐纳入优先审评程序,对于该药来说无疑是又一重大里程碑。此次APG-2575的NDA受理,意味着该药物有望成为国内CLL/SLL领域首个上市的Bcl-2抑制剂,填补临床急需。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212125.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2125909916.SGD","BK1161","LU1923622291.USD","06855","APG","159938","BK1515","09939","BK4129","BK1574","LU2125909759.SGD"],"gpt_icon":0},{"id":"2484268966","title":"亚盛医药-B(06855):APG-2575新药上市申请获中国国家药品监督管理局药品审评中心受理,并被推荐纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2484268966","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484268966?lang=zh_cn&edition=full","pubTime":"2024-11-17 18:33","pubTimestamp":1731839633,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亚盛医药-B 发布公告,公司自主研发的新型选择性 Bcl-2抑制剂APG-2575的新药上市申请已获国家药品监督管理局药品审评中心受理,并被推荐纳入优先审评程序,用于治疗难治或复发性(r/r)慢性淋巴细胞白血病╱小淋巴细胞淋巴瘤。APG-2575是亚盛医药自主研发的新型口服Bcl-2选择性抑制剂,通过选择性抑制Bcl-2蛋白,恢复肿瘤细胞的正常凋亡过程,从而达到治疗肿瘤的目的。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","BK1161","BK1515","BK1574","LU2125909759.SGD","LU2125909916.SGD","APG","BK4129","06855","LU1923622291.USD","159938"],"gpt_icon":0},{"id":"2482422925","title":"Api Group Corporation2024财年第三财季实现净利润69.00百万美元,同比增加27.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482422925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482422925?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:00","pubTimestamp":1731168043,"startTime":"0","endTime":"0","summary":"11月10日,Api Group Corporation公布财报,公告显示公司2024财年第三财季净利润为69.00百万美元,同比增加27.78%;其中营业收入为18.26亿美元,同比增加2.35%,每股基本收益为0.25美元。从资产负债表来看,Api Group Corporation总负债52.78亿美元,其中短期债务94.00百万美元,资产负债比为1.57,流动比率为1.52。机构评级:截至2024年11月10日,当前有9家机构对Api Group Corporation目标价做出预测,其中目标均价为43.22美元,其中最低目标价为36.00美元,最高目标价为50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000101abb0ff85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000101abb0ff85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APG"],"gpt_icon":0},{"id":"2481489939","title":"Api Group Corporation盘中异动 急速拉升5.01%报36.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481489939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481489939?lang=zh_cn&edition=full","pubTime":"2024-11-07 01:47","pubTimestamp":1730915276,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日01时47分,Api Group Corporation股票出现异动,股价大幅拉升5.01%。截至发稿,该股报36.87美元/股,成交量95.3721万股,换手率0.35%,振幅3.79%。Api Group Corporation股票所在的建筑工程行业中,整体涨幅为1.45%。其相关个股中,Construction Partners, Inc.、Matrix Service Company、Tutor Perini Corporation涨幅较大,Blink Charging Co. Common Stock、Primoris Services Corporation、福陆较为活跃,换手率分别为6.16%、2.18%、1.72%,振幅较大的相关个股有Founder Group Limited、阿梅雷斯克、Blink Charging Co. Common Stock,振幅分别为16.00%、12.15%、11.86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107014756aba71776&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107014756aba71776&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APG","LU2125909916.SGD","LU2125909759.SGD","LU1923622291.USD","BK4129"],"gpt_icon":0},{"id":"2481625939","title":"【2024 ASH】 亚盛医药Bcl-2抑制剂APG-2575三项临床研究入选,含1项口头报告!","url":"https://stock-news.laohu8.com/highlight/detail?id=2481625939","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481625939?lang=zh_cn&edition=full","pubTime":"2024-11-06 15:48","pubTimestamp":1730879280,"startTime":"0","endTime":"0","summary":"美国马里兰州罗克维尔市和中国苏州2024年11月6日 /美通社/ --致力于在肿瘤等领域开发创新药物的领先的生物医药企业——亚盛医药今日宣布,公司重点品种APG-2575共有3项临床进展获选第66届美国血液学会年会,其中一项获口头报告。值得一提的是,今年公司四个品种有多项临床和临床前进展入选ASH年会展示及报告,并获两项口头报告。未来,亚盛医药将进一步加速推进临床开发,早日为患者带来更多治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4549381_ZH49381_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["06855","LU2125909916.SGD","BK4129","LU2125909759.SGD","APG","BK1161","LU1923622291.USD","LU2463526074.USD","ASH","BK1574","BK4109"],"gpt_icon":0},{"id":"2481916662","title":"亚盛医药-B(06855):耐立克®、lisaftoclax、APG-5918及APG-2449的多项临床进展将在2024年美国血液学会年会(ASH)展示,其中两项获口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2481916662","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481916662?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:30","pubTimestamp":1730853051,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亚盛医药-B 发布公告,公司共有4个在研新药的多项临床及临床前研究入选第66届美国血液学会年会展示,其中2项获口头报告。这是该品种的临床进展连续第3 年入选ASH年会。耐立克为一种正处于临床研究阶段的化合物,且尚未在美国获得批准。第66届ASH年会将于当地时间2024年12月7 日至2024年12月10日间在美国加州圣地亚哥以线下结合线上的形式举行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207229.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","LU1923622291.USD","BK1574","APG","06855","BK1515","BK4109","LU2125909916.SGD","159938","ASH","LU2125909759.SGD","LU2463526074.USD","BK1161","BK4129"],"gpt_icon":0},{"id":"2476695139","title":"港股异动 | 亚盛医药-B(06855)再涨超4% APG-2449获批开展III期临床研究 赴美上市有望开启新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2476695139","media":"智通财经网","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476695139?lang=zh_cn&edition=full","pubTime":"2024-10-17 10:36","pubTimestamp":1729132608,"startTime":"0","endTime":"0","summary":"亚盛医药-B(06855)再涨超4%,高见46.45港元创三年新高。截至发稿,涨4.62%,报46.45港元,成交额7388.57万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20241017/20241017103658_39381.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20241017/20241017103658_39381.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1195173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["09939","LU1923622291.USD","BK1574","APG","06855","BK1515","III","BK4134","LU2125909916.SGD","159938","LU2125909759.SGD","BK1161","BK4129"],"gpt_icon":0},{"id":"2475988892","title":"港股异动 | 亚盛医药-B(06855)现涨近9% APG-2449获准开展治疗非小细胞肺癌III期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2475988892","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475988892?lang=zh_cn&edition=full","pubTime":"2024-10-16 14:05","pubTimestamp":1729058718,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,亚盛医药-B现涨近9%,截至发稿,涨7.65%,报44.35港元,成交额1.55亿港元。消息面上,亚盛医药近日发布公告,公司原创1类新药APG2449、FAK/ALK/ROS1三联酪氨酸激酶抑制剂,获国家药品监督管理局药物审评中心临床试验许可,将开展针对二代间变性淋巴瘤激酶 TKI耐药或不耐受的非小细胞肺癌患者,或初治ALK阳性晚期或局部晚期NSCLC患者的两项注册III期临床研究。此外,出海合作改善财务状况,赴美上市有望开启新阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1194655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4129","BK4134","BK1515","LU2125909759.SGD","LU1923622291.USD","APG","LU2125909916.SGD","06855","159938","09939","BK1161","BK1574","III"],"gpt_icon":0},{"id":"2473659744","title":"港股异动 | 亚盛医药-B(06855)涨超4% APG-2449获CDE许可开展治疗非小细胞肺癌的注册III期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2473659744","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473659744?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:56","pubTimestamp":1728352583,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,亚盛医药-B涨超4%,截至发稿,涨4.53%,报43.85港元,成交额6812.17万港元。消息面上,亚盛医药-B发布公告,公司原创1类新药APG2449、FAK/ALK/ROS1三联酪氨酸激酶抑制剂,获国家药品监督管理局 药物审评中心临床试验许可,将开展针对二代间变性淋巴瘤激酶 TKI耐药或不耐受的非小细胞肺癌患者,或初治ALK阳性晚期或局部晚期NSCLC患者的两项注册III期临床研究。公告称,这两项都是多中心、开放、随机对照、关键性注册III期临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1190776.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","APG","BK1574","BK1161","06855","09939","CDE","BK4017","BK4134","159938","LU1923622291.USD","BK4129","III","LU2125909759.SGD","LU2125909916.SGD"],"gpt_icon":0},{"id":"2473456896","title":"亚盛医药-B(06855):APG-2449获CDE许可开展治疗非小细胞肺癌的注册III期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2473456896","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473456896?lang=zh_cn&edition=full","pubTime":"2024-10-08 07:56","pubTimestamp":1728345390,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亚盛医药-B 发布公告,公司原创1类新药APG2449、FAK/ALK/ROS1三联酪氨酸激酶抑制剂,获国家药品监督管理局 药物审评中心临床试验许可,将开展针对二代间变性淋巴瘤激酶 TKI耐药或不耐受的非小细胞肺癌患者,或初治ALK阳性晚期或局部晚期NSCLC患者的两项注册III期临床研究。APG-2449是亚盛医药自主研发、具有口服活性的小分子FAK抑制剂,第三代ALK/ROS1 TKI,也是国内首个获CDE许可进行临床试验的FAK抑制剂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1190724.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2125909759.SGD","APG","159938","LU1923622291.USD","06855","LU2125909916.SGD","BK4134","BK4017","III","09939","BK1161","CDE","BK1515","BK1574","BK4129"],"gpt_icon":0},{"id":"2472133563","title":"Crypto反洗钱:国际监管和愈发严格的信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2472133563","media":"TaxDAO","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472133563?lang=zh_cn&edition=full","pubTime":"2024-10-02 10:34","pubTimestamp":1727836444,"startTime":"0","endTime":"0","summary":"本文将对加密资产反洗钱制度的基本概念、面临的挑战、国际规则以及欧盟和美国的监管实践进行总结与分析。","market":"us","thumbnail":"data:image/png;base64,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","type":0,"news_type":0,"thumbnails":["data:image/png;base64,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"],"rights":{"source":"jinse_stock","url":"https://www.jinse.cn/blockchain/3698745.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.jinse.cn/blockchain/3698745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_stock","symbols":["BK4588","BK4156","PSP","BTCW","BK4594","LU2125909759.SGD","MSB","BK4585","HODL","DEFI","APG","ML","BK4006","LU1923622291.USD","GBTC","BK4129","FBTC","BK4166","BRRR","BTCO","LU2125909916.SGD","BITO","EZBC"],"gpt_icon":1},{"id":"2469963372","title":"【金融行动特别工作组(FATF)敦促印度加强虚拟资产监管】金色财经报道,金融行动特别工作组(FATF)周四宣布,在与亚太反洗钱组织(APG)和欧亚集团(EAG)进行联合评估后,印度已“在技术上高度遵守了 FATF 建议,并已采取重大措施实施打击非法融资”。","url":"https://stock-news.laohu8.com/highlight/detail?id=2469963372","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469963372?lang=zh_cn&edition=full","pubTime":"2024-09-21 20:03","pubTimestamp":1726920195,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"'https://api.jinse.com/noah/v2/lives","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK0057","159940","600697","LU1923622291.USD","APG","BK0086","LU2125909916.SGD","BK4129","LU2125909759.SGD","BK0209"],"gpt_icon":0},{"id":"2468665932","title":"亚太股份注资2.5万欧元在德国设立全资子公司APG GmbH","url":"https://stock-news.laohu8.com/highlight/detail?id=2468665932","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468665932?lang=zh_cn&edition=full","pubTime":"2024-09-20 09:06","pubTimestamp":1726794360,"startTime":"0","endTime":"0","summary":"来源:财中社财中社9月20日电亚太股份 发布公告,宣布在德国设立全资子公司“德国亚太有限公司”,注册资本为2.5万欧元。公司已完成相关注册登记,获得法兰克福地方法院商业登记处的注册登记证明。此次投资符合公司发展战略,无需提交董事会和股东大会审议,也不构成关联交易或重大资产重组。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2024-09-20/doc-incpufsw7659038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EUO","BK4129","BK0065","APG","002284","EURmain","BK0264","BK0201","FXE","LU1923622291.USD","MEURmain","LU2125909916.SGD","LU2125909759.SGD"],"gpt_icon":0},{"id":"2458684486","title":"Api Group Corporation2024财年第二财季实现净利润69.00百万美元,同比增加43.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458684486","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458684486?lang=zh_cn&edition=full","pubTime":"2024-08-11 00:12","pubTimestamp":1723306346,"startTime":"0","endTime":"0","summary":"8月11日,Api Group Corporation公布财报,公告显示公司2024财年第二财季净利润为69.00百万美元,同比增加43.75%;其中营业收入为17.30亿美元,同比减少2.32%,每股基本收益为0.25美元。从资产负债表来看,Api Group Corporation总负债51.26亿美元,其中短期债务86.00百万美元,资产负债比为1.56,流动比率为1.48。机构评级:截至2024年8月11日,当前有10家机构对Api Group Corporation目标价做出预测,其中目标均价为43.40美元,其中最低目标价为34.00美元,最高目标价为50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811001231958e7009&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811001231958e7009&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APG"],"gpt_icon":0},{"id":"2457703823","title":"巴克莱:维持APi Gr(APG.US)评级,由增持调整至增持评级, 目标价由44.00美元调整至43.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457703823","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457703823?lang=zh_cn&edition=full","pubTime":"2024-08-06 07:44","pubTimestamp":1722901496,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2125909916.SGD","APG","BK4129","LU2125909759.SGD","LU1923622291.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.apigroupinc.com","stockEarnings":[{"period":"1week","weight":-0.0189},{"period":"1month","weight":0.0256},{"period":"3month","weight":0.0483},{"period":"6month","weight":-0.0348},{"period":"1year","weight":0.0936},{"period":"ytd","weight":0.0671}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"APi Group Corporation是特拉华州的一家公司。该公司是一家全球性的、市场领先的商业服务提供商,在全球500多个地点提供安全和专业服务。该公司向各行各业的长期客户提供法定授权服务和其他合同服务。该公司拥有一种成功的领导文化,这种文化是由向客户提供创新解决方案的创业型商业领袖推动的。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.013636},{"month":2,"riseRate":0.75,"avgChangeRate":0.042101},{"month":3,"riseRate":0.5,"avgChangeRate":0.042551},{"month":4,"riseRate":0.5,"avgChangeRate":-0.023693},{"month":5,"riseRate":0.2,"avgChangeRate":-0.006427},{"month":6,"riseRate":0.6,"avgChangeRate":0.03714},{"month":7,"riseRate":1,"avgChangeRate":0.097729},{"month":8,"riseRate":0.4,"avgChangeRate":-0.035616},{"month":9,"riseRate":0.2,"avgChangeRate":-0.082551},{"month":10,"riseRate":0.8,"avgChangeRate":0.071154},{"month":11,"riseRate":1,"avgChangeRate":0.118547},{"month":12,"riseRate":0.6,"avgChangeRate":0.074594}],"exchange":"NYSE","name":"APi Group Corp","nameEN":"APi Group Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"APi Group Corp(APG)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供APi Group Corp(APG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"APi Group Corp,APG,APi Group Corp股票,APi Group Corp股票老虎,APi Group Corp股票老虎国际,APi Group Corp行情,APi Group Corp股票行情,APi Group Corp股价,APi Group Corp股市,APi Group Corp股票价格,APi Group Corp股票交易,APi Group Corp股票购买,APi Group Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"APi Group Corp(APG)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供APi Group Corp(APG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}